AB PHARMA
ActiveAB PHARMA has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €487k and a net result of €37k. Equity is growing by ~14.9% per year across the filed fiscal years. Its solvency ranks better than 53% of 8092 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
75
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability74▼-3
Solvency83▲+5
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €35k at 30 days acceptable
Liquidity short (current ratio 0.02 against 0.01 in 2023; short-term debt: 39.2% and cash: 0.4% of total assets), and 42.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 29-08-2025, 29 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
29 d late
2023
14 d early
2022
25 d early
2021
29 d late
2020
24 d late
2019
69 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€487k▲ 8.1%
2023 · €450k
2018: €182k
2019: €232k
2020: €285k
2021: €349k
2022: €390k
2023: €450k
2018 → 2024
Total assets
€844k▼ 1.3%
2023 · €855k
2018: €890k
2019: €880k
2020: €872k
2021: €886k
2022: €878k
2023: €855k
2018 → 2024
Net result
€37k▼ 38.8%
2023 · €60k
2018: €26k
2019: €49k
2020: €53k
2021: €64k
2022: €42k
2023: €60k
2018 → 2024
Working capital
€-325k▲ 6.7%
2023 · €-348k
2018: €-526k
2019: €-509k
2020: €-469k
2021: €-424k
2022: €-395k
2023: €-348k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€285k-€349k▲ 22.3%€390k▲ 12.0%€450k▲ 15.3%€487k▲ 8.1%
Operating result€84k-€100k▲ 18.4%€62k▼ 38.1%€85k▲ 38.2%€53k▼ 37.6%
Net result€53k-€64k▲ 19.0%€42k▼ 34.0%€60k▲ 42.7%€37k▼ 38.8%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 38% below 2023 and is the lowest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €844k
Fixed assets
€838k▼ 1.8%
Current assets
€6k▲ 196%
Equity and liabilities €844k
Equity
€487k▲ 8.1%
Debt
€358k▼ 11.7%
The debt ratio falls from 47.4% to 42.3%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€68k▼
2023 · €100k
Cash flow
€52k▼
2023 · €75k
Solvency
57.7%▲
2023 · 52.6%
Current ratio
0.02▲
2023 · 0.01
Quick ratio
0.02▲
2023 · 0.01
Debt / equity
0.73▼
2023 · 0.90
ROE
7.5%▼
2023 · 13.3%
ROA
4.3%▼
2023 · 7.0%
Interest coverage
20.23▼
2023 · 23.05
Debt
€358k▼
2023 · €405k
Debt ≤ 1 year
€331k▼
2023 · €350k
Debt > 1 year
€24k▼
2023 · €52k
Income taxes
€13k▼
2023 · €21k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€855k€844k▼
Fixed assets21/28€853k€838k▼
Tangible fixed assets22/27€252k€237k▼
Land and buildings22€239k€230k▼
Furniture and vehicles24€13k€7k▼
Financial fixed assets28€601k€601k=
Current assets29/58€2k€6k▲
Amounts receivable within one year40/41€592€3k▲
Trade receivables40-€2k
Other amounts receivable41€592€1k▲
Cash at bank and in hand54/58€1k€3k▲
Deferred charges and accrued income490/1€131€55▼
Equity and liabilities
Total equity and liabilities10/49€855k€844k▼
Equity10/15€450k€487k▲
Contributions10/11€20k€20k=
Reserves13€254k€254k=
Distributable reserves133€254k€254k=
Profit (loss) carried forward14€176k€213k▲
Amounts payable17/49€405k€358k▼
Amounts payable after more than one year17€52k€24k▼
Financial debts170/4€52k€24k▼
Amounts payable within one year42/48€350k€331k▼
Current portion of amounts payable after more than one year42€28k€28k▲
Financial debts43€5k€5k▼
Credit institutions430/8€5k€5k▼
Trade debts44€1k€1k▼
Suppliers440/4€1k€1k▼
Taxes, remuneration and social security45€6k€4k▼
Taxes450/3€6k€4k▼
Other amounts payable47/48€309k€293k▼
Accrued charges and deferred income492/3€2k€2k▼
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€15k€15k=
Other operating charges640/8€5k€5k▲
Gross operating margin9900€105k€73k▼
Operating profit (loss)9901€85k€53k▼
Financial charges65/66B€4k€3k▼
Recurring financial charges65€4k€3k▼
Profit (loss) for the period before taxes9903€81k€50k▼
Income taxes67/77€21k€13k▼
Profit (loss) for the period9904€60k€37k▼
Profit (loss) for the period to be appropriated9905€60k€37k▼
Appropriation of the result
Profit (loss) to be appropriated9906€176k€213k▲
Profit (loss) brought forward from the previous period14P€116k€176k▲
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
29-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 29 days late
2024
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
06-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-08
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 29 days late
2021
31-12
Financial
Highest result since 2018net €64k ▲19%
Operating result €100k, net result €64k, both a record.
24-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 24 days late
2020
08-10
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 69 days late
2019
31-12
Financial
Equity above €200kEq €232k ▲27.1%
2 profitable years in a row build equity to €232k.
30-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
25-06
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema
2017
08-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
2016
14-06
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
no sitting director, no change since 2023
We have established no sitting directors for this company. We derive directors from published Gazette acts; while there are none, or none read, nothing appears here. That does not mean the company has none: the CBE keeps its own list of function holders, which we do not read.
14-12-2023
Resigned as Director
Location & real-estate footprint
Registered office, Oud-Turnhout · 1 establishment unit since 2007
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Beukenlaan 92360 Oud-TurnhoutGround area
1,827 m²
Building footprint
239 m²
Parcel 13482F1160/00F002, Flanders. Linked by address, not a title deed.
1 establishment unit
AB PHARMA
since 20072.158.644.235
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13482F1160/00F002 | Flanders | 1,827 m² | 1 · 239 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
MITHOS
BE 0666.751.670
Hasselt · Eq €487k
HEYLEN BUSINESS SERVICES
BE 0895.551.411
Scherpenheuvel-Zichem · Eq €487k
FM CONSULTING
BE 0644.756.921
Schilde · Eq €487k
MERCOPATI
BE 0463.831.234
Gent · Eq €487k
Nico Immo
BE 0434.425.287
Sint-Truiden · Eq €487k
Of 82,569 companies in sector 70200 we hold annual accounts for 52,573. 34,854 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded24-11-2006
Fiscal year end31-12
Activities, NACEBEL
70200Business and other management consultancy
70220Business consulting
74142
Sources
Crossroads Bank for EnterprisesNational Bank · 18 filingsAddress and cadastre registers
Data from official sources, last processed on 20-09-2026. Scores and ratios are computed by Checked and are not a credit decision.